EAM Investors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

EAM Investors’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-600,317	Closed	-$2.8M	–	405
2017 Q1	$2.8M	Buy	+600,317	New	+$3.48M	0.44%	109
2016 Q4	–	Sell	-526,602	Closed	-$2.9M	–	408
2016 Q3	$2.9M	Buy	+526,602	New	+$2.47M	0.39%	108
2016 Q1	–	Sell	-647,686	Closed	-$3.67M	–	384
2015 Q4	$3.67M	Buy	+647,686	New	+$3.95M	0.48%	61
2015 Q3	–	Sell	-670,346	Closed	-$5.56M	–	383
2015 Q2	$5.56M	Buy	+670,346	New	+$3.25M	0.65%	13

Other funds holding SGYP

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

EAM Investors's SGYP Position: Q2 2017 in Review

EAM Investors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2017, closing a stake of 600,317 shares — an estimated $2.8M sold.

EAM Investors first reported a position in SGYP in Q2 2015 and held it in 4 quarters. The position peaked at $5.56M in Q2 2015. 146 funds tracked by Wall St. Rank hold SGYP as of Q2 2017.

EAM Investors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2017 after selling out during the quarter.
EAM Investors sold 600,317 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2017, an estimated $2.8M.
EAM Investors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2015 and held it in 4 quarters.
EAM Investors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $5.56M in Q2 2015.
146 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2017.

Based on EAM Investors's 13F filing for Q2 2017, filed 11 Aug 2017.